Surmodics Common Stock Net 2010-2025 | SRDX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Surmodics common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Surmodics common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$229.7B
Boston Scientific (BSX)	$155.9B
Stryker (SYK)	$147.1B
EssilorLuxottica (ESLOY)	$145.9B
Medtronic (MDT)	$116.8B
Lonza Group Ag (LZAGY)	$49.2B
Haleon (HLN)	$44B
ResMed (RMD)	$42.2B
GE HealthCare Technologies (GEHC)	$33.4B
Agilent Technologies (A)	$33.3B
Terumo (TRUMY)	$27.3B
Koninklijke Philips (PHG)	$26.4B
Insulet (PODD)	$23.1B
Zimmer Biomet Holdings (ZBH)	$20.7B
Smith & Nephew SNATS (SNN)	$16.2B
Baxter (BAX)	$12.2B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$7.7B
Lantheus Holdings (LNTH)	$4B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.4B
Perrigo (PRGO)	$3.2B
Prestige Consumer Healthcare (PBH)	$3.2B
ICU Medical (ICUI)	$3B
Haemonetics (HAE)	$2.6B
LeMaitre Vascular (LMAT)	$2.2B
Acuren (TIC)	$2.1B
Curaleaf Holdings (CURLF)	$1.9B
Green Thumb Industries (GTBIF)	$1.8B